Cyteir Therapeutics

Market Research - Lexington, Massachusetts, US

Cyteir Therapeutics Details

Cyteir was a clinical-stage oncology company focused on the development of CYT-0851, an oral investigational drug that inhibits monocarboxylate transporters. Cyteir had CYT-0851 in development in combination with capecitabine and gemcitabine in a Phase 1/2 clinical study, including patients with advanced ovarian cancer.

Cyteir Therapeutics logo, Cyteir Therapeutics contact details
Employees: 50 - 99
HQ: (857) 285-4140
Location: Lexington, Massachusetts, US
Revenue: $8.5 million
Cyteir Therapeutics Autoimmunity
Cyteir Therapeutics Technologies
Captcha

reCAPTCHA

Email Providers

Outlook

Widgets

BugHerd

CMS

WP Engine

Other

Mobile Friendly

Analytics and Tracking

Google Analytics

View All Technologies Used At Cyteir Therapeutics

Contacting Cyteir Therapeutics: Connect with Executives and Employees

Get in Touch with Cyteir Therapeutics Executives and Employees

Connecting with Cyteir Therapeutics's Executives and Workforce

Accessing Contact Information for Cyteir Therapeutics Executives

Connecting with Cyteir Therapeutics: Reach Out to Their Team

Discover How to Contact Cyteir Therapeutics Executives and Staff

Looking to connect with Cyteir Therapeutics executives or employees?

Seeking to Get in Touch with Cyteir Therapeutics Executives or Staff?

Want to Reach Out to Cyteir Therapeutics Executives or Team Members?

In Search of Contact Details for Cyteir Therapeutics Professionals?

Connecting with Cyteir Therapeutics: Contacting Executives and Staff

Browse companies
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z